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Introduction
The most basic definition of stem cells says, that they
are cells with the capacity to self renew and to differ-
entiate into specialized cells. This definition, thanks to
its simplicity, is still valid despite of constant updates
in this field. There are different types of stem cells.
The most primitive is totipotent zygote and its imme-
diate progeny – primordial cells. They can give rise to
all tissue and organs including placenta, but this is a
transient population without  ability to self-maintain
and that is why it is called prestem cells. At the stage
of blastocyst cells originating from inner cells mass are
termed embryonic stem cells (ESC). They are  pluripo-
tent, which means the capability to differentiate into
all three germ layers, but not into placenta any more
(this is a unique feature of trophoblast stem cells). Fur-
ther development cause the appearance of cells with a
confined potency to differentiate into one of germ
layer. They are called multipotent stem cells and can
give rise to either endoderm, mesoderm or ectoderm
[1,2]. With time of growing, the ability to multilineage
differentiation gradually decreases and most of cells
are directed onto certain path of development. Initial-
ly, stem cells were associated only with the prenatal
stage, but later they were found also in all tissues and
organs of adult organisms. Adult stem cells (ASC) are
considered to be a peculiar regeneration reserve of
organisms and became the hope of regenerative medi-
cine. Using of adult stem cells gives the possibility of
carrying out autologous transplantations, where donor
and host is the same individual. Autologous grafts
should not induce adaptive immune response, which is
the most serious barrier of transplantology. Problems
which limit routine use of adult stem cells in regener-
ative medicine reslult from relatively low number of
these cells and objective difficulties with isolation of
many ASC types (for example cardiac or nervous stem
cells) [1]. However, some populations of adult stem
cells, for example those derived from skeletal muscles
(SM) or bone marrow (BM) are relatively easy to iso-
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late and are considered as promising material for autol-
ogous transplantations. Obtaining a muscle biopsy or
bone marrow sample from both human or animal is an
easy and low invasive procedure. These cells are myo-
genic, what enables working on new methods of treat-
ment muscle diseases. Surveys regarding the clinical
application of myogenic cells refer mainly to muscle
dystrophies, myocardial infarction, urinary inconti-
nence or local traumatic injury of muscle.
Myogenic stem cells
Myogenic stem cells are cells with the ability to dif-
ferentiate into muscle fibers. There are still a lot of
controversies concerning origin, potential and charac-
teristic features of different subpopulations of this het-
erogenous group. The most important populations of
cells which are recognized as myogenic stem cells are:
satellite cells, multipotential muscle derived stem cells
(MMDSCs) and bone marrow mesenchymal stem cells
(BM-MSCs) called also multipotent mesenchymal
stromal cells (the last name is recommended by Inter-
national Society for Cellular Therapy [3]. There is also
a recently described population of pluripotent stem
cells (PSC) residing in adult tissues, which also have
myogenic potential and can contribute in muscle
regeneration [4].
Satellite cells
Satellite cells are undifferentiated, mononuclear cells
located between basal lamina and sarcolemma of mus-
cle fiber. For the first time they were described by
Alexander Mauro in 1961. At the beginning of 90-ties
this population seemed to be well recognized, but
within the last decade a lot of controversies around
satellite cells have appeared. Currently it is clear, that
the location between basal lamina and sarcolemma
does not unambiguously characterize the cell type. It is
heterogenous group either concerning phenotype, ori-
gin or the level of differentiation. However, one main
population can be marked off within this group. This
population will be here called "typical" satellite cells.
During embryonic development "typical" satellite
cells migrate from the dorsal compartment of the
somite – dermomyotome [7]. The transcription factor
Pax7 is considered to be the key protein conditioning
the presence and myogenic determination of "typical"
satellite cells. Seale et. al. [8] described the complete
absence of satellite cells in animals without expression
of Pax7. However, the subsequent publication of Ous-
tanin et al [9] revealed, that muscle of pax7-/- mice
contain a reduced but substantial number of satellite
cells. At the same time, muscle regeneration was
impaired in adult pax7-/- mutant mice what confirmed
the essential role of Pax7 in myogenesis. Moreover, it
is thought that the presence of Pax7 is required for
MyoD expression [10], but in animals pax7-/- this
function can be, at least partially, taken over by Pax3
protein [11]. Besides Pax7, "typical" satellite cells
express also M-cadherin, c-met, foxk1, CD34 [12-14].
Satellite cells possessing such a phenotype are gener-
ally considered as unipotent stem cells with the ability
to differentiate into myogenic, but not any other cell
linage. These cells constitute the regeneration pool of
postmitotic muscle fibers. In normal conditions satel-
lite cells remain quiescent, but muscle injury activate
them. They start proliferating and expressing muscle
regulatory factors (MRF) proteins – Myf5 and MyoD.
The proliferative phase takes about 2-5 days following
injury. In this time myoblasts (satellite cells progeny),
expand in response to stimuli released by damaged
muscle fibers and inflammatory cells recruited to the
area. The process is also modulated by extracellular
matrix proteins. Eventually, about 5-7 days following
injury, myoblasts withdraw from cell cycle and begin
to differentiate which is conditioned by expression of
myogenin and finally – myosin heavy chain (MyHC)
[15]. They can fuse with each other creating new fibers
or joining already existing ones. The proliferative
potential of satellite cells is quite remarkable. It was
demonstrated that as few as seven satellite cells asso-
ciated with one myofiber can regenerate a hundred or
more new myofibers containing thousands of myonu-
clei [16]. Apart from ability to proliferate and differen-
tiate satellite cells can divide asymmetrically to
reestablish a pool of residual undifferentiated cells
within the muscle [16,17]. This capacity is very impor-
tant because it decides about numbering satellite cells
among adult stem cells. Satellite cells are one of few
populations of stem cells which can be relatively easy
isolated from an adult organism – obtaining a piece of
skeletal muscle weighting few grams is an invasive,
but not very upsetting intervention. Moreover, satellite
cells are comparatively numerous group – approxi-
mately 2-5% of nuclei in muscle of adult mouse
belong to this population [18]. These features decide
about considering satellite cells as a good material for
autologous transplantations in cases of muscle dys-
function. 
Multipotential muscle-derived stem cells
(MMDSC)
During last decade of the 20th century it was found
out that a population of undifferentiated cells in skele-
tal muscles is more heterogenous then it was previous-
ly thought. The presence of cells with the potential of
mesenchymal stem cells was revealed in muscles of
birds, rabbits and human beings [19]. Depending on
isolation method or described features they are called
either muscle-derived stem cells (MDSCs) [20], skele-
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tal muscle side population (SMSP) [21], or muscle-
derived hematopoietic stem cells (MD-HSCs) [22]. It
is not clear whether these cells are differently called
but are in fact the same population or if they are rather
distinct groups of cells. In recent years several trials
were performed in order to fully characterize undiffer-
entiated cells situated in skeletal muscles. In any case,
many points concerning their origin, potency and func-
tions remain to be elucidated.
To describe muscle stem cell phenotype the pres-
ence of stem cell antigen-1 (sca-1), CD34 (marker of
hematopoietic and satellite cells), CD45, c-kit (mark-
ers of hematopoietic cells) and desmin (marker of
myogenic cells) were determined (Table 1). Conflict-
ing data were reported [21-28], what can suggest that
several distinct populations of multipotential muscle-
derived stem cells exist. On the other hand, obtaining
various expression profiles could be caused by using
different methods of protein detection – western blot,
immunocytochemistry or flow cytometry. Finally,
depending on the cell status (quiescent, proliferating,
differentiating, apoptotic) the protein expression
change dynamically in cells derived from muscle
explants what can be another explanation of diversity
of results [29-31]. The results were consistent merely
with regard to sca-1 expression – all studies demon-
strated that multipotential muscle derived stem cells
are positive for this protein. 
Generally, two different methods of MMDSC iso-
lation can be distinguished. The first method,
described by group of researchers from Pittsburgh, is
based primarily on differences in adhesion properties
of cells [32]. Cells obtained by enzymatic digestion of
muscle tissue are seeded on a culture dish and after 1
h the medium and nonadherent cells are transferred to
another dish (preplating). Next, analogous preplates
are repeated at 24 h intervals until preplate 6 (pp6) is
completed (Fig. 1B). The cells which rapidly attach to
the surface are mainly fibroblasts (pp1), cells which
adhere within 24-48 h are predominantly satellite cells
403Myogenic stem cells
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2008:46(4): 403 (401-412) 
doi: 10.2478/v10042-008-0060-1
Table 1. Characterization of multipotential muscle-derived stem cells obtained by different methods of isolation.
M – myogenic potency, H – hematopoietic potency, O – osteogenic potency, im – intramuscular injection, iv – intravenous injection, n.d. – not determined
(pp2 – pp4) and the population which settle the most
slowly on a flask consist multipotential stem cells (pp-
6) [32]. The phenotype of fraction pp6 was described
as sca-1+, CD34+, CD45-, c-kit- with the expression
of desmin on a different level. This population is called
muscle-derived stem cells (MDSC). MDSCs cultured
in vitro differentiate spontanously into myotubes, but
also, when appropriately stimulated (by addition of
growth factors to the medium or transduction with cer-
tain genes) these cells can give rise either to
osteoblasts [27], chondroblasts [33], hematopoietic
cells [18] or endothelial cells [34]. Additionally, it was
shown, that population of sca-1+, CD45-, c-kit- SM-
derived cells display also cardiomyogenic potential [6]
however, the higher cadriomyogenic potency was
demonstrated in sca-1- subpopuation of SM-derived
cells. Muscle-derived stem cells participate into mus-
cle regeneration following intramuscular injection.
Interestingly, they were also found in muscles after
intravenous administration, and their number was
higher in muscles previously injured then in control
ones [28]. Alternatively,  MDSCs can contribute into
bone or cartilage repair, but only after transduction
with BMP-2 or BMP-4 (bone morphogenetic protein)
[27,33].
To sum up, cells called MDSC can be recognized as
multipotential, but with distinct tendency to myogenic
differentiation. Presented results indicate that the poor-
er cells adhere to the flask surface the more undiffer-
entiated state they have. The expression of desmin
gradually decrease with subsequent preplates and in
pp6 population only about 10-20% of cells are positive
for this protein [25,28]. However, pp6 cells cultured in
standard conditions spontaneously enter the myogenic
pathway what is associated with increased desmin
expression [32]. It explains results obtained by Lee et.
al. [27] and Jankowski et. al. [35] who have demon-
strated that the majority of MDSCs was positive for
desmin. Studies regarding cell viability after trans-
plantation have shown that more MDSC survive fol-
lowing intramuscular administration comparing to
more differentiated cells (myoblasts). After injection
of the same number of either MDSC or early preplate
(EP) cells, the contribution to muscle regeneration 30
and 90 d later was even 10 time higher in MDSC
group. Marked differences were probably associated
with the distinct immunogenicity between MDSCs and
EP cells. The evaluation of MHC-1 expression on cell
membranes of both cell types revealed that MHC-1
was present on 63% of EP cells whereas only on 0.5%
of MDSCs. However, MDSC is a much less numerous
cell population comparing to "typical" satellite cells
which dominate in EP group. Only one clone of
MDSC can be obtain from 105 of cells originally iso-
lated from muscle tissue [32]. 
The second, frequently used method of isolation of
muscle-derived multipotential stem cells is sorting
them by flow cytometry after staining with Hoechst
33324 (Fig. 1A). Cells obtained with this technique are
called skeletal muscle side population (SMSP). Unfor-
tunately, the description "side population" characterize
only the ability to efflux the dye and does not define
the features or function of these cells. It is considered
that ATP-binding cassete (ABCG2) protein is respon-
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Fig. 1. Two methods of MMDSC
isolation. The muscle explants are
minced and digested. A. Cells
released from the muscle tissue are
stained with Hoechst 33342 and
analyzed by FACS. Cells which dis-
play increased dye efflux are called
skeletal muscle side population
(SMSP). B. The technique based on
adherence properties – cells are
seeded at a flask and after 1 h the
medium and non-adherent cells are
moved to another dish. Analogous
preplates are repeated at 24 h inter-
vals until preplate 6 (pp6) is com-
pleted. This population is called
MDSC.
sible for the phenotype of SP cells [36,37]. Initially,
the term "side population" was associated mainly with
a subpopulation of hematopoietic stem cells [38].
However, later studies revealed that high level of
ABCG2 expression and effluxing the Hoechst 33342
dye characterize some types of stem cells in other tis-
sues and organs (for example skeletal muscle tissue,
mammary gland or lungs [21,39,40] and also some
cancer cells [41]). Therefore, side population pheno-
type is rather associated with low level of differentia-
tion then certain features or origin of cells. 
Skeletal muscle side population has been character-
ized as sca-1+, CD34+, CD45+/-, c-kit+/-, desmin-
[18,21]. SMSP cells are spherical and poorly adhere on
the dish surface [42], in which they resemble MDSC
population. Evaluating of differentiation potential
revealed that SMSP can give rise into all hematopoet-
ic lines both in vitro and in vivo [21,23]. The question
of myogenic potential is more complex. Asakura et. al.
[21] demonstrated that SMSP cells harvested in vitro
do not differentiate spontaneously into myocytes.
However, the co-culture of lac-Z-expressing SP cells
with primary myoblasts caused the formation of small
number (3.8%) of multinucleated myotubes that coex-
pressed lacZ and desmin. These results indicate that
cell-mediated inductive interactions are needed to
induce myogenic potential of SMSP. Interestingly,
only CD45- subpopulation of SP cells possesses such
a capability – CD45+ SP cells do not undergo myo-
genic specification even when co-cultured with
myoblasts. Myogenic potential of SP was also tested in
the in vivo studies. Side population cells contribute to
new fibers formation after injecting into muscle
injured with cardiotoxin. Moreover, they can be found
in the position of satellite cells after transplantation.
However, CD45- subpopulation cells differentiate into
muscle fibers in a higher percent then CD45+ cells,
what confirm in vitro studies [21,22]. Regardless of
hematopoietic and myogenic potential, SMSP display
also endothelial trait (CD31+) [43]. Moreover, it was
shown that SMSP expresses angiopoietin 2 and the
Tie2 receptor, which is bound and activated by
angiopoietins [24]. It means, that most of the SMSP
cells share partially signaling pathways with endothe-
lial/hematopoietic precursor cell populations.
In terms of myogenic specification of SMSP cells,
interesting observation was done by Asakura et. al.
[21]. They demonstrated that lacking of Pax7 gene in
experimental animals does not influence the number
of muscle SP cells. Furthermore, Pax7-/- SP cells can
differentiate into myotubes when cocultured with
myoblasts what indicate that Pax7 gene is not
required for myogenic specification of SMSP cells.
Finally, forced expression of MyoD induced myo-
genic differentatiation of Pax7-/- SP cells but not
pax7-/- myoblasts [21]. All this data suggest that
SMSP and satellite cells are distinct populations and
probably have different origin. On the other hand,
results of Seale et. al. [10] indicate, that Pax7 is nec-
essary and sufficient for the myogenic specification
of CD45+, sca-1+ muscle-derived cells (subpopula-
tion of SMSP). Therefore, to elucidate the role of
Pax7 in myogenesis of SMSP cells, further studies
are required.
Pluripotent stem cells (PSC) from adult 
tissues
One more type of cells is postulated as potentially con-
tributing to regeneration of skeletal muscles. This is a
rare population called very small embryonic like
(VSEL) stem cells. These cells were identified by
group of researchers from Louisville [4]. It was found
that VSELs express markers of pluripotent stem cells
such as SSEA-1, Oct-4, Nanog and Rex-1 and Rif-1
telomerase protein. As it was mentioned before,
pluripotency means the ability to differentiate into
cells from all three germ layers. Therefore, VSEL stem
cells display also myogenic potential. This is hypothe-
size that PSC are deposited during gastrulation and
organogenesis in developing organs/tissues. They were
found for example in adult bone marrow, lungs,
myocardium, liver [2]. Until now, it was not demon-
strated that VSELs are present in adult skeletal mus-
cles, however, another group of researchers found in a
murine SM a rare population of cells which displayed
myogenic, adipogenic and neurogenic potential, what
suggest pluripotency [5]. Moreover, the expression of
several markers of PSC (Oct-4, Nanog, Rex-1, Rif-1)
were identified at transcript level in cells isolated from
skeletal muscles [6]. The expression of PSC markers
was higher in sca-1- subpopulation of SM-derived
cells then in sca-1+ cells. 
Origin of myogenic stem cells
It has been established that "typical" satellite cells
(committed muscle progenitors) originate from the
dorsal compartment of the somite, the dermomyotome
and that Pax3/Pax7 are the key factors to direct embry-
onic cells into myogenicity [7,44]. The issue of origin
of multipotential muscle-derived stem cells is more
problematic. Schienda et. al. [45] demonstrated that at
least part of SMSP cells arise from hypaxial somite
and, similarly to satellite cells, they are localized in
skeletal muscle as early as during embryonic period.
On the other hand, numerous studies indicate that
SMSP are derived from bone marrow. It has been
shown, that both acute and chronic injury of muscle
result in mobilization of mesenchymal stem cells from
bone morrow to the peripheral blood [47]. Circulating
bone marrow-derived cells are able to settle in skeletal
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muscle and contribute to their regeneration [18,42,48-
50]. Intravenously injected bone marrow cells were
found in muscle even 13 years after transplantation
[51]. From the other side, intravenous administration
of male-derived unfractionated bone marrow cells into
female mdx mice resulted in formation of dystrophin-
expressing Y-chromosome-positive muscle fibers
already after 8 weeks [42]. Following analogous injec-
tion of the same number of bone marrow main popula-
tion (BMMP) and bone marrow side population
(BMSP) the regeneration of muscle was 100 fold more
effective in the case of BMSP transplantation [52].
This suggests that stem cells finding niche in skeletal
muscle during postnatal life are derived mainly from
bone marrow side population. However, as mentioned
above, the term "side population" does not specify the
type of cells in details. Considering the fact, that some
of multipotential muscle-derived stem cells
(MMDSCs) display expression of hematopoietic
marker CD45, and the other part is negative to this
protein, it is likely, that both hematopoietic and mes-
enchymal bone marrow stem cells can migrate into
skeletal muscle and constitute, at least in part,
MMDSCs population. 
The mechanism, which determines mobilization of
cells from bone marrow and homing them in the mus-
cle tissue is not completely elucidated. Generally, it is
recognized, that damaged muscle release signals
(chemokines, growth factors), which, on the basis of
chemical gradient, attract circulating stem cells (SC) to
the injured area [53,54]. Up to date, the role of several
factors has been demonstrated in homing of circulating
SC to the muscle tissue. Among them are hepatocyte
growth factor (HGF), stromal-derived factor-1 (SDF-
1), leukemia inhibitory factor (LIF), insulin-like
growth factor-1 (IGF-1) [53-55]. The presence of
appropriate receptors (c-met, CXCR4, LIF-R) on a
cells surface allows the release from the bone marrow
and decide about trafficking certain cell type to the
area with the high concentration of corresponding lig-
and. Regarding to the muscle tissue, CXCR4/SDF-1
axis is suggested to play a crucial role in settlement of
non-hematopoietic stem cells in skeletal muscles
[53,56], whereas hematopoietic stem cells are proba-
bly trafficked by the c-met/HGF axis [54]. The pres-
ence of CXCR4 receptor on hematopoietic stem cells
and the fact, that muscle tissue is a SDF-1 positive
stem cell niche suggest, that CXCR4/SDF-1 interac-
tion can also contribute to homing of HSC in muscle
[57], however, the results of Rosu-Myles et. al. [54]
does not confirm this hypothesis.
The migration of BM-derived SC outside from the
blood vessel is possible due to the presence of adhe-
sion molecules as integrins or selectins on the cell sur-
face [58]. There are some factors influencing stem
cells homing. It has been demonstrated, that regenerat-
ing muscle incorporate more circulating cells then
noninjured one [18]. Interestingly, also physiologic
stresses encountered by healthy organisms throughout
life enhance homing of circulating SCs in the muscle
[59]. Moreover, it was demonstrated, that the level of
incorporation of BM cells depends also on muscle type
[60].
Bone marrow derived cells, which settled in the
muscle tissue, gradually change their phenotype and
differentiation potential under the impact of local sig-
nals released by myogenic environment. McKinney-
Freeman et. al. [49] analyzed the phenotype of CD45+
cells isolated directly from bone marrow in compari-
son to the same cell population after homing in the
muscle. They reported considerable downregulation of
c-kit protein in the settled cells (over 1000-fold) and
significantly lower potency to repopulate hematopoiet-
ic lineages (22-fold). In another study, comparative
microarray analysis of BMSP and SMSP revealed that
expression of over 50% of examined genes differed in
these two populations [15]. Moreover, long term stud-
ies demonstrated, that BM-derived cells can be local-
ized with time in the position of satellite cells and are
positive for M-cadherin [50] (The comparison of "typ-
ical" and other types of muscle satellite cells is sum-
marized in Table 2). 
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Table 2. Comparison of “typical” and other muscle satellite cells.
There is an agreement, that "typical" satellite cells
originating from dermamyotome constitute the basic
regenerative reserve of skeletal muscle tissue which is
present already in the prenatal period. However, all
data cited above indicate, that this "somitic" pool is
supplemented throughout life by cells derived from
bone marrow (both hematopoietic and mesenchymal).
These cells are mobilized and trafficked during exer-
cises, injuries and probably other conditions which
remain unknown until now. Initially, BM-derived cells
settle in the interstitial tissue in the neighborhood of
blood vessels and display relatively low myogenic
potential. Yet, the environment of regenerating muscle
enhance myogenic determination, so, with time, cells
derived primarily from bone marrow or their progeny
can enter satellite cells position and begin to express
markers of myogenic precursors [10,18,50,61]. The
settlement of BM-derived cells in skeletal muscles has
been schematically illustrated in Fig. 2. It is likely, that
MDSCs obtained by using preplating method are the
progeny of BM-derived cells on succeeding levels of
myogenic differentiation. Therefore, subsequent sub-
populations (from pp6 to pp2) display the rising
expression of myogenic marker – desmin, and the low-
ering expression of undifferentiated cells marker – sca-
1. [25,28]. Interestingly, not all cells located in satellite
cell position are terminally determined to myogenic
differentiation [62]. Therefore, we propose the follow-
ing sequence of events: first, MDSCs reach the local-
ization beneath basal lamina and afterwards they can
acquire (not necessarily) the phenotype of myogenic
precursors. Such a hypothesis can explain results,
where mesenchymal potential of satellite cells was
described [31,62], although they are generally consid-
ered to be determined myogenic precursors. In the
study of Sherwood et. al. [18] bone marrow cells were
transplanted retroorbitally, and the effect was evaluat-
ed after 4 – 12 weeks. Grafted cells were found in
skeletal muscles both in interstitial tissue and in the
position of satellite cells. Additionally, among cells
isolated from muscle explants, the population with the
highest myogenic activity was analyzed. These cells
displayed CD45-, sca-1-, Mac-1-, CD34+, CXCR4+,
β1-integrin+ characteristics. Interestingly, cells with
such a phenotype were not found among the popula-
tion derived from BM and settled in the muscle. Thus,
BM-derived cells can not (at least within 12 weeks)
reach the phenotype of typical muscle progenitors. On
the other hand, LaBarge et. al. [61] demonstrated, that
the contribution of bone marrow-derived satellite cells
to muscle regeneration increased in animals after 6
months of exposure to a running wheel. The number of
new muscle fibers created with participation of BM-
derived cells arise up to 3.5% of all myofibers (com-
paring 0.16% in non-exercised control animals).
Importantly, BM-derived cells homed in muscle tis-
sue contribute not only to the regeneration of muscle
fibers. It was demonstrated, that BM-derived CD45+,
sca-1+ cells isolated from skeletal muscle and trans-
planted to another muscle took part in a vascular
regeneration (both of endothelium and smooth muscle
layer) [48]. 
It was demonstrated, that beside hematopoietic and
mesenchymal stem cells, also small amount of pluripo-
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Fig 2. Proposed relationship
between BM-derived stem cells,
MMDSC and satellite cells. Both
HSC and MSC are released from
bone marrow to the peripheral blood
as an answer to certain stimuli (for
example exercises or injuries). They
are trafficked by gradient of
chemokines or growth factors and
settle in various tissue and organs
(in this case in skeletal muscle). At
the beginning they are located in
interstitial tissue in the neighbor-
hood of blood vessels and at this
level can be classified as multipotent
muscle stem cells. Their phenotype
is gradually changed and determina-
tion into myogenic pathway increas-
es. With time, MMDSCs can enter
satellite cell position and finally are
able to become muscle precursor
cell expressing Pax7. Nevertheless,
the large majority of satellite cells
(more then 95%) are cells originat-
ing from dermamyotome.
tent stem cells can be mobilized from bone marrow
into peripheral blood during skeletal muscle damage
[46] VSEL stem cells are considered to be a mobile
pool of primitive stem cells which can contribute to
regeneration of different tissue and organs depending
on the current needs.
Muscle regeneration potential during aging
Myogenic stem cells become a new material for autol-
ogous transplantations in human patients. Therefore,
the question about features and potential of this popu-
lation in aging organisms seems to be very important.
It is known, that the muscle regeneration capability
decrease with age [63]. The mechanism of this impair-
ment has not been completely elucidated yet. In term
of clinical applications it is crucial to establish what is
the predominant cause of declining regenerative
potency of skeletal muscle. Are these an age-related
changes in number or features of myogenic stem cells
(cell intrinsic factors) or rather alterations in the sur-
rounding environment (cell extrinsic factors)?
The results of studies concerning the correlation of
age with the number of muscle stem cells (usually
satellite cells) are unequivocal. Depending on the
examined species, type of muscle or methodology
which has been used, the number of muscle stem cells
was decreased, maintained or it increased with age
[64]. There are studies indicating that, not the quanti-
ty, but the appropriate activation and efficient prolifer-
ation before terminal differentiation has the key impact
on regeneration ability of skeletal muscle. It has been
suggested that changes in the expression of Noth and
Wnt factors can be important in aging muscle. It was
shown that the regulation of Notch signaling controls
satellite cell activation and proliferation in postnatal
myogenesis [65], whereas the initiation of differentia-
tion is Wnt dependent. In aged muscle, Wnt signaling
is increased in early activated satellite cells [66] and, at
the same time, the activation of Notch receptor is
impaired [67]. This results in premature shifting from
proliferation phase to differentiation and finally leads
to less regeneration ability in aging organisms. How-
ever, it was observed, that this trend is reversible, thus,
depends on extrinsic factors. Exposure of aged satellite
cells to young systemic environment restored appro-
priate activation of Notch receptor and prolonged pro-
liferation phase [68]. Another significant age-related
feature of satellite cells is increased tendency to con-
vert to fibroblasts in the in vitro culture. Yet, also in
this case, exposure of aged cells to serum derived from
young animals caused the decline of myogenic-to-
fibrogenic conversion. Thus, increased fibrosis
observed in aging muscle seems to be related to the
environmental conditions. Others extrinsic changes
which are considered to influence the regeneration
capacity are reduced skeletal muscle capillarization
[69] and thickening of basal lamina surrounding the
muscle fibres [70] in aged compared to young organ-
isms. Both of these factors can hinder the access of dif-
ferent stimuli to the muscle and can have an impact on
settlement and fate of mesenchymal stem cells derived
from BM [71]. To summarize, most of studies indicate,
that extrinsic influences play predominant role in age-
related impairment of muscle regeneration. The most
distinct confirmation of such a hypothesis are experi-
ments with using heterochronic parabiotic pairs of ani-
mals (where the circulation of young and old animal is
crossed by surgical joining). It was demonstrated that
the muscles of older partner in such a pair displayed
enhanced regeneration capability and decreased fibro-
sis. The effect observed in young animal was opposite
[66]. Nevertheless, the cell intrinsic changes in aging
muscle are not meaningless. Among irreversible cell
features influencing impaired regeneration potential of
aging muscle the most important seems to be telomere
shortening and increased tendency to undergo apopto-
sis [64].
Mesenchymal stem cells
As mentioned before, bone marrow mesenchymal
stem cells (BM-MSCs) are also considered as myo-
genic stem cells. Mesenchymal stem cells have been
recognized to be multipotent, what means the ability to
differentiate into all cell types originating from one
germ leyer (mesodermal in this case). Indeed, it was
demonstrated that MSCs can give rise to osteoblasts,
chondroblasts, adipocytes [72] and also skeletal mus-
cle cells [73,74], cardiomyocytes [75,76] and smooth
muscle cells [78]. The ease of obtaining bone marrow
sample and myogenic potential of MSCs make this
population an attractive candidate for cellular trans-
plantation in cases of diseases associated with muscle
dysfunction [77]. However, there are still a lot of con-
troversies around the level of myogenic potential of
mesenchymal cells. Some researchers claim that the
whole population of MSCs can be differentiated into
myoblasts, if appropriately treated [73], whereas other
authors indicate, that only little proportion of BM-
MSCs displays myogenic potential [79-81]. Numerous
studies were focused on the methodology of induction
of MSCs differentiation into muscle cells. First reports
pointed to the DNA methyltransferase inhibitor – 5-
azacitidine as the factor initializing myogenesis of
MSCs [82]. Some studies confirm, that the addition of
5-azacitidine to the culture medium induces the
expression of myogenic cells marker – desmin [75] or
cardiomyocytes markers – β-myosin heavy chain and
cardiac troponin-T [76,83] in harvested MSCs. On the
other hand, there are reports questioning such an effect
of 5-azacitidine. Chan et. al. [84] tested different con-
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centrations of this factor and did not observed expres-
sion of any of myogenic markers but massive death of
treated cells. Similarly, Liu et. al. [85] demonstrated
no expression of cardiomyocytes markers in MSCs
exposed to 5-azacitidine. Finally, studies of Balana et.
al. [86] indicated that 5-azacitidine induces differen-
tiation of MSCs into neither myoblasts nor cardiomy-
ocytes, but can change electrophysiological proper-
ties of treated cells. Another factor proposed as
potential inducer of myogenic differentiation of
MSCs is galectin-1 [84]. Previously, it was shown
that galectin-1 is capable to convert mouse dermal
fibroblasts to the myogenic lineage [87]. Up to date,
an effect of galectin-1 activity on mesenchymal stem
cells was not confirmed by other researchers. Regard-
ing myogenic potential of BM-MSCs, an interesting
data were reported by Dezawa et. al. [73]. They
described the methodology, which allows for differ-
entiation of primary pool of MSCs into muscle cells
with efficacy of 89%. To obtain such a high differen-
tiation rate, MSCs were cultured in a medium con-
taining mixture of cytokines and growth factors
(bFGF, forskolin, PDGF i neuregulin) and subse-
quently transfected with gene encoding Notch 1
intracellular domain (NICD). Following this proce-
dure, cells described as muscle-MSCs (M-MSCs)
expressed myogenic markers (Myo-D, myogenin)
and fused into myotubes (fusion index amounted to
20%). Moreover, M-MSCs were positive for tran-
scription factor Pax7 and c-met receptor, which are
well known specific markers of satellite cells. 
Alternative approach to induce myogenesis in
MSCs is the exposure of these cells to myogenic envi-
ronment. Studies verifying this conception were per-
formed both in vitro [74,88] and in vivo [89]. It is
known, that cells release cytokines to the surrounding
environment and can modify the fate of neighboring
cells in a paracrine way. Additionally, changes in genes
expression can be induced by direct cell-to-cell inter-
actions. Indeed, GFP (green fluorescent protein) posi-
tive mesenchymal stem cells co-cultured with car-
diomycytes or satellite cells differentiated in either
cardiac cells [88] or myotubes [74] respectively. These
results confirm both the significance of cell-to-cell
interaction and the presence of myogenic potential of
MSCs. However, the differentiation rate in these con-
ditions was highly limited. Among multinucleated
myotubes only 1-2% revealed the expression of GFP.
The fate of mesenchymal stem cells injected into either
skeletal or cardiac muscle was also analyzed. It was
demonstrated that undifferentiated MSCs can undergo
myogenesis after intramuscular administration, but
similarly to the in vitro studies, the proportion of dif-
ferentiated cells was barely detectable – only 0,44% of
transplanted MSCs fused in myotubes [90]. Interesting
study was conducted by Nassiri et. al. [89] where the
efficacy of MSCs transplantation with and without
prior differentiation was compared. Cells were inject-
ed around the myocardial infarction are experimental-
ly induced in a rabbit model. Improvement in left ven-
tricular function, vascular density and reduction of
infarcted area did not differ significantly between two
groups. The perspective to transplant undifferentiated
mesenchymal stem cells seems to be promising,
because it does not require time-consuming and
expensive extracorporeal manipulations on cells. On
the other hand, the more undifferentiated the cells are,
the higher risk of neoplastic transformation exists [91].
Nonetheless, further studies are needed to confirm the
results obtained by Nassiri et. al. [89].
Conclusions and perspectives
Clearly, the biology of myogenic stem cells is very
complex. There are still a lot of questions which
remain to be elucidated. It is important to establish in
what extent BM-derived muscle stem cells support
physiological regeneration of skeletal muscle. Are they
significant players or rather have marginal meaning?
Moreover, how can we influence the level of mobi-
lization of bone marrow cells and their settlement in
the muscle tissue? Multipotential MDSC seems to be a
promising population, but its rarity seriously limits the
possibility of clinical use. The same, but in even wider
extend, refers to pluripotential stem cells. Therefore,
further work on improving the techniques of isolation
and expansion of MMDSCs and adult PSC should be
conducted. In term of future clinical applications the
choice of the best cell type for transplantation should
be established. There is a variety of conditions where
the transfer of myogenic stem cells can be good for
medical practice (for example: muscular dystrophies,
myocardial infarction, urinary incontinence). There-
fore, it is likely, that for each of dysfunction, different
cell type can be the best option. Due to real perspective
of performing autologous myogenic stem cells trans-
plantations in human patients it is crucial to understand
more profoundly age-related changes in regeneration
capacity of muscle. Such a knowledge allows for elab-
oration novel strategies of improving cellular transfer
in older patients.
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